Posted on

MCA concludes successful visit to Canada and United States

MCA concludes successful visit to Canada and United States
MCA Chief Executive Officer Dr Jerrol Thompson presents update on North America visit. On his left is Chief Inspector Terral Mapp and (r) Deputy Chair of the MCA Board of Directors Lennie Adams.

Share

Chief Executive Officer Dr Jerrol Thompson and Chief Inspector Terral Mapp of the Medicinal Cannabis Authority (MCA), have concluded a successful regulatory assessment visit to Canada and the United States.

The main purpose of their visit was to meet with Ample Organics, a Canadian Seed-to-Sale (Track and Trace) Software company that provides 70% of the Track and Trace services in Canada. Seed-to-Sale systems are used to track the logistics and use of cannabis from its cultivation, processing, patient use and export. They provide a means to identify diversions of cannabis into the illegal market, the unusual patterns of patient use and the financial compliance associated with its use.

As a consequence of this visit, Ample will provide the MCA with a draft proposal to review and sign in order to commence the process between them. Ample will also provide a Patient Access Database software for the MCA-Patient Access system.

The MCA has dedicated a section of its Standard and Compliance Regulations to Track and Trace, considered to be a critical aspect of regulatory compliance.

The MCA CEO and Chief Inspector also visited 15 other entities including a processing facility, laboratory, green- house, outdoor grow facility, dispensary and the New York Department of Health.

While on their visits the MCA team was supported by SVG Ambassador to the United States, Ambassador Lou-anne Gilchrist, Counsel General Ambassador to Canada Fitz Huggins, Bernadette Ambrose Black of the New York Consulate and former Director of the Information Technology Services Division Andre Bailey.

LAST NEWS